JoinClinicalTrials.com

Results

Hot

Post your clinical trial on JoinClinicalTrials.com

Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

• A Study of S6G5T-3 in the Treatment of Acne Vulgaris

  NCT03761784

  Condition:   Acne Vulgaris
  Interventions:   Drug: S6G5T-3;   Drug: S6G5T-8
  Sponsor:   Sol-Gel Technologies, Ltd.
  Recruiting
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

  NCT03526861

  Condition:   Atopic Dermatitis
  Interventions:   Drug: Tralokinumab;   Drug: Placebos
  Sponsor:   LEO Pharma
  Recruiting
• Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

  NCT04015375

  Condition:   Acne Vulgaris
  Interventions:   Drug: Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd);   Drug: ACZONE® (dapsone) gel, 7.5% (Allergan, INC.);   Other: Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)
  Sponsors:   Torrent Pharmaceuticals Limited;   Catawba Research
  Recruiting
• A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

  NCT04104685

  Condition:   Acne Vulgaris
  Interventions:   Combination Product: FCD105;   Drug: 3% Minocycline Foam;   Drug: 0.3% Adapalene Foam;   Other: Vehicle Foam
  Sponsor:   Foamix Ltd.
  Recruiting
• Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

  NCT03916081

  Condition:   Atopic Dermatitis
  Interventions:   Drug: ARQ-151 cream 0.05%;   Drug: ARQ-151 cream 0.15%;   Drug: ARQ-151 cream Vehicle
  Sponsor:   Arcutis, Inc.
  Recruiting
• Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

  NCT03903822

  Condition:   Atopic Dermatitis
  Interventions:   Drug: PF-06700841;   Drug: Vehicle (Placebo)
  Sponsor:   Pfizer
  Recruiting
• A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma

  NCT03769090

  Condition:   Asthma
  Interventions:   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg;   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg;   Combination Product: Albuterol sulfate metered-dose inhaler 180 μg
  Sponsor:   Bond Avillion 2 Development LP
  Recruiting
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

  NCT03691649

  Condition:   Glaucoma and Ocular Hypertension
  Interventions:   Drug: DE-117 Ophthalmic Solution;   Drug: Timolol Maleate Ophthalmic Solution 0.5%
  Sponsor:   Santen Inc.
  Recruiting
• Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

  NCT03664739

  Condition:   Acne Vulgaris
  Interventions:   Drug: IDP-120 Gel;   Drug: IDp-120 Vehicle Gel
  Sponsor:   Bausch Health Americas, Inc.
  Recruiting
• Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension

  NCT03450629

  Conditions:   Open Angle Glaucoma;   Ocular Hypertension
  Interventions:   Drug: Brimonidine Tartrate Ophthalmic Suspension;   Drug: Brimonidine Tartrate Ophthalmic Solution
  Sponsor:   Sun Pharma Advanced Research Company Limited
  Recruiting